Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma? Kartolo A, Robinson A, Vera Badillo FE. Eur Urol 2023;83:1-2.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kartolo A, Robinson A, Vera Badillo FE. Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma? Eur Urol 2023;83:1-2.
PMID: 35606230